• English
  • Eesti

    Humaanravimi müügiluba uuendati tähtajatult (seisuga 02.04.2019)

    03.04.2019
    Printer-friendly version
    Müügiloa hoidjaRavimi nimetusATC koodToimeainedRavimvorm, tugevus, pakendi suurusMüügiloa numberKuuluvused
    Ebewe Pharma Ges.m.b.H Nfg.KGEBETREX 10MG/MLL01BA01metotreksaatinj 10mg/ml 0,75ml N1; 0,75ml N4; 0,75ml N5; 1ml N1; 1ml N4; 1ml N5; 1,5ml N1; 1,5ml N4; 1,5ml N5; 2ml N1; 2ml N4; 2ml N5644609R
    Egis Pharmaceuticals Public Limited CompanyDELIPID PLUSC10BA06rosuvastatiin+esetimiibcaps 10mg+10mg N7; N10; N28; N30; N56; N60; N84; N90850014R
    Egis Pharmaceuticals Public Limited CompanyDELIPID PLUSC10BA06rosuvastatiin+esetimiibcaps 20mg+10mg N7; N10; N28; N30; N56; N60; N84; N90849914R
    Egis Pharmaceuticals Public Limited CompanyDELIPID PLUSC10BA06rosuvastatiin+esetimiibcaps 40mg+10mg N7; N10; N28; N30; N56; N60; N84; N90849814R
    Iasis Pharmaceuticals Hellas S.A.ZALEPINN05AH03olansapiinsuus dispergeeruv tabl 5mg N28; N56845114R
    Iasis Pharmaceuticals Hellas S.A.ZALEPINN05AH03olansapiinsuus dispergeeruv tabl 10mg N28; N56845214R
    Iasis Pharmaceuticals Hellas S.A.ZALEPINN05AH03olansapiinsuus dispergeeruv tabl 15mg N28; N56845314R
    Iasis Pharmaceuticals Hellas S.A.ZALEPINN05AH03olansapiinsuus dispergeeruv tabl 20mg N28; N56845414R
    PRO.MED.CS Praha a.s.TADALAFIL PMCS 5 MGG04BE08tadalafiiltabl 5mg N2; N4; N8; N10; N12; N20; N30; N50; N100852114R
    PRO.MED.CS Praha a.s.TADALAFIL PMCS 10 MGG04BE08tadalafiiltabl 10mg N2; N4; N8; N10; N12; N20; N30; N50; N100852014R
    PRO.MED.CS Praha a.s.TADALAFIL PMCS 20 MGG04BE08tadalafiiltabl 20mg N2; N4; N8; N10; N12; N20; N30; N50; N100851914R
    UAB NoramedaBOSENTAN NORAMEDA 62,5 MGC02KX01bosentaantabl 62,5mg N14; N56; N112829613R
    UAB NoramedaBOSENTAN NORAMEDA 125 MGC02KX01bosentaantabl 125mg N14; N56; N112829513R